New TAVI Tussle But It’s Edwards In The Dock
This article was originally published in Clinica
Executive Summary
Just over a year after settling a long legal wrangle with Medtronic over patents related to transcatheter aortic valve implantation technology, Edwards Lifesciences is once again becoming embroiled in another TAVI suit – this time, however, it is the one accused of infringement.
You may also be interested in...
Edwards Letting German Centers Stock-Up On Sapien 3 Ahead Of Patent Ruling
As its dispute with Boston Scientific over transcatheter aortic valve replacement technology patents rumbles on, Edwards Lifesciences is offering German interventionalists the option to buy six-months' worth of its Sapien 3 inventory in anticipation of a potential disruption to the supply flow.
Could Alcon's CyPass Trouble Be Boon For Glaukos – Or Bust For MIGS?
Minimally invasive glaucoma surgery specialist Glaukos saw its stock leap 40% in the wake of a worldwide recall by much bigger rival Alcon of its CyPass microstent.
Roche Dx' EMEA Head To Take Charge After Diggelmann Departs
Roland Diggelmann will end his decade-long career at Roche Diagnostics at the end of September. The business's head of EMEA Michael Heuer will take Diggelmann's place while the search is on for his replacement.